Stephanie Anita Vogt graduated from the University of Basel with a Master in Drug Sciences in April 2022.

She conducted her Master's thesis "Development and characterization of β2-integrin modulators as tool compounds to elucidate their role in immune modulation" in the Molecular Pharmacy Group at the University of Basel under the supervision of Prof. Dr Daniel Ricklin.

In May 2022, she started her PhD in the Molecular Pharmacy group under the supervision of Prof. Dr. Daniel Ricklin, in cooperation with the Biopharmacy group under the supervision of Prof. Dr. Henriette Meyer zu Schwabedissen. Stephanie's goal is a design, synthesis and evaluation of peptidic complement inhibitors of the compstatin family with improved target and species binding properties.